Research Analysts Set Expectations for BBIO FY2027 Earnings
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Equities research analysts at Leerink Partnrs cut their FY2027 EPS estimates for shares of BridgeBio Pharma in a research report issued to clients and investors on Sunday, November 24th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of $1.30 for ...
Publicado el: 2024-11-28 07:15:16
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
